4LD-19712-83936
3 vaccinations
3 coded responses
7 check-ins
2 free-text entries
2 call cases
- Sex
- Female
- Age at first dose
- 0-4
- ZIP prefix
- 152 / PA
- Registered
- 2022-06-27
- Relationship
- Child or adolescent in my care
- Guardian
- P8X-27234-96470
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2022-05-04
Dose 1 — Pfizer-BioNTech
-
2022-05-25
Dose 2 — Pfizer-BioNTech
-
2022-06-27
Registered in v-safe
- 2022-06-27
- 2022-06-29
- 2022-07-06
-
2022-07-26
Dose 3 — Pfizer-BioNTech
- 2022-08-26
-
2022-09-11
Survey response — day 42, dose 3, under 3MedDRA: Cough, Pyrexia — Feeling: Good · Be unable to work or attend schoolFree text: Fever and coughMedDRA releases: 2024-11 · check-in free text available
-
2022-10-25
Survey response — 3 months, dose 3, under 3MedDRA: Ear infection, Nasopharyngitis — Feeling: Fair · Be unable to work or attend school, Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visitFree text: Bad cold that turned into ear infectionMedDRA releases: 2024-11 · check-in free text available
-
2022-10-25
Report sent to call center — 3 months, dose 3, under 3Be unable to work or attend school · Get care from a doctor or other healthcare professionalOutpatient clinic or urgent care clinic visit · 1 call case(s)
-
2022-10-26
Call successfulNot applicable – Participant does not believe symptoms are related to vaccine and does not wish to fill
-
2023-01-24
Survey response — 6 months, dose 3, under 3MedDRA: COVID-19 — Feeling: Fair · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visitMedDRA releases: 2024-11
-
2023-01-24
Report sent to call center — 6 months, dose 3, under 3Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare prOutpatient clinic or urgent care clinic visit · 1 call case(s)
- 2023-01-25
- 2023-01-27
-
2023-01-27
Callback requested for01:00PM ET
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2022-05-04 | Pfizer-BioNTech | No |
| 2 | 2022-05-25 | Pfizer-BioNTech | No |
| 3 | 2022-07-26 | Pfizer-BioNTech | No |
Call center
2 call center cases
1 successful · 1 unsuccessful
Free text
Release 12 (Under 3) — day 42, dose 3, under 3
Symptoms: Fever and cough
Release 12 (Under 3) — 3 months, dose 3, under 3
Symptoms: Bad cold that turned into ear infection
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Cough | · | · | ✓ |
| SD | COVID-19 | · | · | ✓ |
| SD | Ear infection | · | · | ✓ |
| SD | Nasopharyngitis | · | · | ✓ |
| SD | Pyrexia | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release